BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30678708)

  • 21. Epstein-Barr Virus-Induced VEGF and GM-CSF Drive Nasopharyngeal Carcinoma Metastasis via Recruitment and Activation of Macrophages.
    Huang D; Song SJ; Wu ZZ; Wu W; Cui XY; Chen JN; Zeng MS; Su SC
    Cancer Res; 2017 Jul; 77(13):3591-3604. PubMed ID: 28484077
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epstein-Barr virus mir-bart1-5p detection via nasopharyngeal brush sampling is effective for diagnosing nasopharyngeal carcinoma.
    Zheng XH; Lu LX; Cui C; Chen MY; Li XZ; Jia WH
    Oncotarget; 2016 Jan; 7(4):4972-80. PubMed ID: 26701721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF-κB pathway.
    Huang W; Liu J; Feng X; Chen H; Zeng L; Huang G; Liu W; Wang L; Jia W; Chen J; Ren C
    Med Oncol; 2015 Apr; 32(4):115. PubMed ID: 25779535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
    Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
    J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pathological roles of BART miRNAs in nasopharyngeal carcinoma.
    Lo AK; Dawson CW; Jin DY; Lo KW
    J Pathol; 2012 Aug; 227(4):392-403. PubMed ID: 22431062
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of circulating EBV microRNA BART2-5p in facilitating early detection and screening of nasopharyngeal carcinoma.
    Jiang C; Chen J; Xie S; Zhang L; Xiang Y; Lung M; Kam NW; Kwong DL; Cao S; Guan XY
    Int J Cancer; 2018 Dec; 143(12):3209-3217. PubMed ID: 29971780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.
    Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G
    Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Involvement of EBV-encoded BART-miRNAs and dysregulated cellular miRNAs in nasopharyngeal carcinoma genesis.
    Xie YJ; Long ZF; He XS
    Asian Pac J Cancer Prev; 2013; 14(10):5637-44. PubMed ID: 24289555
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma.
    Horikawa T; Yang J; Kondo S; Yoshizaki T; Joab I; Furukawa M; Pagano JS
    Cancer Res; 2007 Mar; 67(5):1970-8. PubMed ID: 17332324
    [TBL] [Abstract][Full Text] [Related]  

  • 30. c-Src activation promotes nasopharyngeal carcinoma metastasis by inducing the epithelial-mesenchymal transition via PI3K/Akt signaling pathway: a new and promising target for NPC.
    Ke L; Xiang Y; Guo X; Lu J; Xia W; Yu Y; Peng Y; Wang L; Wang G; Ye Y; Yang J; Liang H; Kang T; Lv X
    Oncotarget; 2016 May; 7(19):28340-55. PubMed ID: 27078847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hes1 triggers epithelial-mesenchymal transition (EMT)-like cellular marker alterations and promotes invasion and metastasis of nasopharyngeal carcinoma by activating the PTEN/AKT pathway.
    Wang SC; Lin XL; Wang HY; Qin YJ; Chen L; Li J; Jia JS; Shen HF; Yang S; Xie RY; Wei F; Gao F; Rong XX; Yang J; Zhao WT; Zhang TT; Shi JW; Yao KT; Luo WR; Sun Y; Xiao D
    Oncotarget; 2015 Nov; 6(34):36713-30. PubMed ID: 26452025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BART miRNAs: an unimaginable force in the development of nasopharyngeal carcinoma.
    Wang Y; Guo Z; Shu Y; Zhou H; Wang H; Zhang W
    Eur J Cancer Prev; 2017 Mar; 26(2):144-150. PubMed ID: 26909566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
    Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
    Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of EBV on WIF1, NLK, and APC gene methylation and expression in gastric carcinoma and nasopharyngeal cancer.
    Zhao Z; Liu W; Liu J; Wang J; Luo B
    J Med Virol; 2017 Oct; 89(10):1844-1851. PubMed ID: 28543390
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MiR-744 functions as a proto-oncogene in nasopharyngeal carcinoma progression and metastasis via transcriptional control of ARHGAP5.
    Fang Y; Zhu X; Wang J; Li N; Li D; Sakib N; Sha Z; Song W
    Oncotarget; 2015 May; 6(15):13164-75. PubMed ID: 25961434
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-149 promotes epithelial-mesenchymal transition and invasion in nasopharyngeal carcinoma cells.
    Luo Z; Zhang L; Li Z; Jiang C; Dai Y; Liu X; Zheng Y; Yu H; Xiang J; Li G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jul; 36(7):604-9. PubMed ID: 21873783
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-1178-3p promotes the proliferation, migration and invasion of nasopharyngeal carcinoma Sune-1 cells by targeting STK4.
    Wang LQ; Deng AC; Zhao L; Li Q; Wang M; Zhang Y
    J Biol Regul Homeost Agents; 2019; 33(2):321-330. PubMed ID: 30972994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flotillin-2 promotes nasopharyngeal carcinoma metastasis and is necessary for the epithelial-mesenchymal transition induced by transforming growth factor-β.
    Zhao L; Lin L; Pan C; Shi M; Liao Y; Bin J; Liao W
    Oncotarget; 2015; 6(12):9781-93. PubMed ID: 25909165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA expression profiling analysis in serum for nasopharyngeal carcinoma diagnosis.
    Zou X; Zhu D; Zhang H; Zhang S; Zhou X; He X; Zhu J; Zhu W
    Gene; 2020 Feb; 727():144243. PubMed ID: 31743768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. microRNA-342-3p targets FOXQ1 to suppress the aggressive phenotype of nasopharyngeal carcinoma cells.
    Cui Z; Zhao Y
    BMC Cancer; 2019 Jan; 19(1):104. PubMed ID: 30678643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.